Benitec Biopharma (BNTC) Net Equity Issued and Repurchased (2019 - 2021)
Benitec Biopharma (BNTC) posted Net Equity Issued and Repurchased of $14.3 million for Q2 2021, up 475000.0% sequentially from $3000.0 in Q1 2021.
Powered by 
Analysis
Benitec Biopharma (BNTC) Net Equity Issued and Repurchased (2019 - 2021) Analysis & Trends
Benitec Biopharma has reported Net Equity Issued and Repurchased for 2 years, with the latest figure at $14.3 million in Q2 2021.
- Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $14.3 million in Q2 2021, while the trailing twelve-month figure through Mar 2022 was $14.3 million (up 475100.0% YoY) and the FY2023 annual result came in at $17.9 million, changed N/A from the prior year.
- Net Equity Issued and Repurchased advanced to $14.3 million in Q2 2021 per BNTC's latest filing, from $3000.0 in the prior quarter.
- Over five years, Net Equity Issued and Repurchased peaked at $14.3 million in Q2 2021 and troughed at $3000.0 in Q1 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 49.20 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 141.90 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Benitec Biopharma | 588.88 Mn | 588.88 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2021 | 14.25 Mn |
| Mar 31, 2021 | 3,000.00 |
| Sep 30, 2019 | 2.25 Mn |